Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126433-07-6

Post Buying Request

126433-07-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126433-07-6 Usage

Uses

Tyrphostin 51 has been used to study the inhibition of rat hepatic leptin 1.

Biochem/physiol Actions

Tyrphostin 51 is a small molecule inhibitor of epidermal growth factor (EGF) receptor kinase function. This molecule associates with the substrate subsite of the protein tyrosine kinase (PTK) domain,.

Check Digit Verification of cas no

The CAS Registry Mumber 126433-07-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,4,3 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 126433-07:
(8*1)+(7*2)+(6*6)+(5*4)+(4*3)+(3*3)+(2*0)+(1*7)=106
106 % 10 = 6
So 126433-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H8N4O3/c14-4-8(12(17)9(5-15)6-16)1-7-2-10(18)13(20)11(19)3-7/h1-3,18-20H,17H2/b8-1+

126433-07-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (T7665)  Tyrphostin 51  ≥98%

  • 126433-07-6

  • T7665-5MG

  • 1,363.05CNY

  • Detail
  • Sigma

  • (T7665)  Tyrphostin 51  ≥98%

  • 126433-07-6

  • T7665-25MG

  • 5,483.79CNY

  • Detail

126433-07-6Downstream Products

126433-07-6Relevant articles and documents

Tyrphostins I: Synthesis and Biological Activity of Protein Tyrosine Kinase Inhibitors

Gazit, Aviv,Yaish, Pnina,Gilon, Chaim,Levitzki, Alexander

, p. 2344 - 2352 (2007/10/02)

A novel class of low molecular weight proteine kinase inhibitors is described.These compounds consitute a systematic series of molecules with a progressive increase in affinity toward the substrate site of the EGF receptor kinase domain.These competitive inhibitors also effectively block the EGF-dependent autophosphorylation of the receptor.The potent EGF receptor kinase blockers examined were found to competitively inhibit the homologous insulin receptor kinase at 102-103 higher inhibitor concentrations in spite of the significant homology between these protein tyrosine kinases.These results demonstrate the ability to synthesize selective tyrosine kinase inhibitors.The most potent EGF receptor kinase inhibitors also inhibit the EGF-dependent proliferation of A431/clone 15 cells with little or no effect on EGF independent cell growth.These results demonstrate the potential use of protein tyrosine kinase inhibitors as selective antiproliferative agents for proliferative diseases caused by the hyperactivity of protein tyrosine kinases.We have suggested the name "tyrphostins" for this class of antiproliferative compounds which act as protein tyrosine kinase blockers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126433-07-6